ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ASLN ASLAN Pharmaceuticals Ltd

0.5312
0.0402 (8.19%)
Apr 18 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 303,858
Bid Price 0.52
Ask Price 0.53
News -
Company Name Stock Ticker Symbol Market Type
ASLAN Pharmaceuticals Ltd ASLN NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.0402 8.19% 0.5312 18:52:28
Open Price Low Price High Price Close Price Prev Close
0.491 0.491 0.58 0.54 0.491
Trades Volume VWAP Dollar Volume Avg Volume
785 303,858  0.5323583  161,761 -
Last Trade Time Type Quantity Stock Price Currency
19:43:50 20  0.52 USD

ASLAN Pharmaceuticals Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 0.00 - 0 -51.38M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News ASLAN Pharmaceuticals

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ASLN Message Board. Create One! See More Posts on ASLN Message Board See More Message Board Posts

ASLN Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

ASLAN Pharmaceuticals Ltd is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. The company is evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease.

Your Recent History

Delayed Upgrade Clock